Sun Pharma Gets Green Signal from FDA for Wellbutrin

by Rajshri on  April 8, 2010 at 9:52 PM Drug News
RSS Email Print This Page Comment
 Sun Pharma Gets Green Signal from FDA for Wellbutrin
Indian drugmaker Sun Pharmaceuticals has announced that it has got approval from the U.S. regulatory authorities to market a generic version of GlaxoSmithKline's Wellbutrin SR extended release tablets.

The company, which is in trouble in Israel, said that the FDA approved its application to market a generic version of Wellbutrin on Thursday.

Wellbutrin is an antidepressant medication and works in the brain to treat major depressive disorder and seasonal affective disorder


Source: Medindia
RAS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive